Avon Talc Verdict Upheld: Court Affirms $51M Mesothelioma Award

California's Second District Court of Appeal upheld a $51 million mesothelioma verdict against Avon Products on February 11, 2026, ruling that asbestos-contaminated talc in its cosmetic powders caused Rita-Ann Chapman's fatal cancer [1]. The court rejected all four of Avon's challenges and certified the opinion for publication, making it binding precedent across California [13]. People diagnosed with mesothelioma after using cosmetic talc can explore their options with a mesothelioma legal claim.

Key Facts: The Avon Talc Verdict and Appeal

What Did the California Appeals Court Decide in the Avon Talc Case?

On February 11, 2026, the California Court of Appeal for the Second Appellate District, Division Eight, affirmed the judgment against Avon Products in its entirety [1]. The case is captioned LAOSD Asbestos Cases (Gary Chapman v. Avon Products, Inc.), No. B327749. On March 4, 2026, the court certified the opinion for publication — a procedural step that transforms it from a one-case ruling into binding precedent that other California courts must follow.

The judgment under review came from a 2022 trial in Los Angeles County Superior Court before Judge Lawrence P. Riff. After a lengthy trial, the jury returned a special verdict for the plaintiffs, finding Avon strictly liable for selling products with inadequate warnings and with defects in manufacture and design. The jury also found Avon liable for negligence, fraudulent misrepresentation, and fraudulent concealment, and found that Avon had acted with malice, oppression, or fraud — the legal predicate for punitive damages [1].

The jury awarded $40,831,453 in compensatory damages and $10.3 million in punitive damages against Avon, apportioning Avon 90 percent at fault [1]. The roughly $51 million attributable to Avon is the figure the appellate court left fully intact.

"When an appellate court certifies an opinion for publication, it is telling every trial judge and every defendant in the state that this reasoning is now the law. That is what makes the Chapman decision matter beyond one family. Avon took its best shot on appeal — four separate arguments — and the court rejected all of them."

— Rod De Llano, Founding Partner, Danziger & De Llano

Who Was Rita-Ann Chapman and How Was She Exposed to Avon Talc?

Rita-Ann Chapman began using Avon talcum powder products in 1954, when she was eight years old [1]. She used the products multiple times per week until 1978, then resumed use from 1995 through 2010. At some point before 2021, she was diagnosed with malignant mesothelioma — a cancer of the lining of the lungs and other organs caused by asbestos exposure [6].

Chapman and her husband brought their damages action in 2021 against several dozen defendants. By the time trial started, only Avon and a forklift manufacturer, Hyster-Yale Group, remained as defendants [1]. Rita-Ann Chapman died on March 16, 2025, a little over two years after the verdict; her husband Gary Chapman continued the case as her successor-in-interest.

Her exposure history illustrates why cosmetic-talc mesothelioma cases can take decades to surface. Mesothelioma has a latency period of 20 to 50 years between first asbestos exposure and diagnosis [7]. Chapman's first Avon exposure in 1954 and her diagnosis more than six decades later fall squarely within that pattern — and explain why people who used these products in childhood are still being diagnosed today.

What Did Avon's Own Documents Reveal About Asbestos in Its Talc?

The most damaging evidence at trial came from Avon's own files. Talc and asbestos are minerals that form together in the same geological deposits, and the appellate opinion noted that it is now undisputed that there is no way to remove asbestos from talc [1]. Avon's internal records show the company understood this risk in the early 1970s.

The opinion catalogs a series of Avon memos. In an October 1971 memo, Avon acknowledged asbestos in four sources of its talc — as high as 12 percent tremolite, one of the amphibole forms of asbestos. A December 1971 memo stated that three named talc sources "all contain the asbestos form called Tremolite and we recommend that their use in any Avon product be discontinued immediately." By January 1972, one talc source was reported to contain 20 to 25 percent tremolite, described as "largely fibrous," "very abundant," and "very poor and possibly dangerous" [1].

The documentation continued. A March 1972 analysis showed several Avon talcs contained tremolite reaching up to 25 percent. In November 1972, Avon admitted that "samples of each of our current talcs will contain asbestos forms, particularly tremolite," and in December 1972 the company determined it was not feasible to remove tremolite from its talc [1].

"You rarely see a paper trail this clear. Avon did not just fail to test — its own memos identified asbestos in its talc, recommended discontinuing the sources, and then concluded the contamination could not be removed. The jury read those documents and concluded the company had acted with malice. The appellate court agreed there was ample evidence to support that finding."

— Rod De Llano, Founding Partner, Danziger & De Llano

The plaintiffs also relied on independent scientific testing. Dr. William Longo, whose laboratory is the only one in the United States accredited to analyze cosmetic talc for amphibole asbestos using both Polarized Light Microscopy and Transmission Electron Microscopy, tested more than 90 vintage samples of Italian talc — examined through period bottles of Colgate Cashmere Bouquet — and more than 77 percent tested positive for amphibole asbestos [1]. Peer-reviewed literature has documented the same pattern: a published case series of 75 mesothelioma patients found cosmetic talc to be the only identifiable asbestos source in every case [2], and earlier work established asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women [4]. You can read more about this contamination history on the WikiMesothelioma page covering asbestos in consumer products.

Why Did Avon's Appeal Fail?

Avon appealed on four claims of error — three narrow and one broad [1]. It argued the trial court wrongly admitted testimony from the Chapmans' expert Dr. William Longo about the presence of asbestos in Avon talc; wrongly excluded testimony from Avon's own witness on disclosure grounds; wrongly permitted the Chapmans' medical expert Dr. Steven Haber to opine on asbestos testing methods and the meaning of Avon's internal documents; and that there was no reliable evidence that Avon talc contained asbestos or caused Chapman's mesothelioma.

The court rejected every argument. It held that Avon had waived its challenge to the sufficiency of the evidence and waived part or all of each of its challenges to the admission or exclusion of evidence. Beyond waiver, the court found that Avon had failed to show error or abuse of discretion in the trial court's evidentiary rulings [1]. Appellate courts review a trial judge's evidentiary decisions deferentially, overturning them only for a clear abuse of discretion — a standard Avon could not meet.

The practical effect is that the full judgment stands. There was no reduction, no new trial, and no narrowing of the liability findings. For a defendant that mounted a comprehensive challenge to both the science and the trial process, a complete affirmance is a decisive loss.

What Does the Chapman Ruling Mean for Cosmetic Talc Victims?

The Chapman decision strengthens the position of people diagnosed with mesothelioma after using cosmetic talc, for several reasons.

First, it is published precedent. A certified-for-publication opinion can be cited as controlling authority in California courts, and it endorses the methods plaintiffs use to prove these cases — expert testing of vintage product samples, reliance on a manufacturer's internal documents, and medical causation testimony connecting asbestos-contaminated talc to mesothelioma [1]. Future defendants will face an appellate opinion that has already upheld this approach.

Second, it confirms that talc liability is not limited to Johnson & Johnson. While J&J dominates the headlines, the Avon judgment shows that any manufacturer whose talc was contaminated with asbestos can be held fully accountable — a point underscored by parallel litigation against other brands, which we cover in our analysis of the Vi-Jon talc trial and non-J&J manufacturers.

Third, it reinforces the regulatory trajectory. In July 2024, the International Agency for Research on Cancer upgraded talc to Group 2A, "probably carcinogenic to humans," for all routes of exposure, while talc containing asbestiform fibers remains a Group 1 carcinogen [5]. At the same time, the FDA has no current mandatory requirement for manufacturers to test cosmetic talc for asbestos — a gap we examine in our coverage of the FDA's withdrawal of its talc testing rule [9].

"Many people who used cosmetic powders for decades assume that because they never used a particular brand, they have no claim. The Chapman case shows the opposite. The question is not whose label was on the container — it is whether the talc inside was contaminated with asbestos. The science and the verdicts increasingly answer that question the same way."

— Rod De Llano, Founding Partner, Danziger & De Llano

How Does the Avon Verdict Fit the Broader Talc Litigation Landscape?

The Avon affirmance lands amid a wave of cosmetic-talc litigation. Johnson & Johnson faces more than 90,000 talc claims and has tried three times to resolve them through subsidiary bankruptcy — each attempt rejected by federal courts, as detailed in our report on the dismissal of J&J's third talc bankruptcy. Recent talc mesothelioma verdicts have ranged into the hundreds of millions and beyond, a trend tracked in our overview of multi-billion-dollar talc jury verdicts.

What distinguishes the Avon case is its posture. Many large talc defendants have sought the shelter of bankruptcy reorganization rather than litigate every claim to final judgment. Avon, by contrast, litigated the Chapman case through trial and a full appeal — and lost on every issue. The result is one of the few published appellate opinions to test, and affirm, the core evidentiary framework of a cosmetic-talc mesothelioma case.

For victims, the existence of multiple responsible companies can be an advantage. Many mesothelioma patients qualify to pursue claims against more than one defendant and against asbestos bankruptcy trusts simultaneously — a strategy explained on the WikiMesothelioma pages covering asbestos trust funds and the mesothelioma lawsuit process.

What Should You Do If You Used Avon Talc and Developed Mesothelioma?

If you or a family member used Avon — or any other brand of talc-based powder — and later received a mesothelioma diagnosis, a few steps protect your options:

• Document your product use history. Note which talc products you used, the approximate years, and where you bought them. Childhood and early-adulthood use matters, even if it was decades ago. Avon's direct-sales model means many users received products from a representative rather than a store, so any detail helps an attorney reconstruct the timeline.
• Preserve any medical records confirming the mesothelioma diagnosis, including pathology reports identifying the cancer type and any asbestos-fiber analysis of lung or tissue samples.
• Do not assume bankruptcy ends your claim. Reorganizations channel asbestos liability into structured processes rather than eliminating it. The Chapman judgment was affirmed despite Avon's corporate restructuring.
• Act within the statute of limitations. In most states the clock starts at diagnosis, not at exposure, and the timelines are short. Early consultation preserves your ability to pursue every available source of compensation.
• Consult a mesothelioma attorney. These cases require tracing product supply chains and marshaling scientific and corporate evidence. The right firm handles that work on a contingency basis — no fee unless you recover.

Avon's own documents, the testing data, and now a published appellate opinion all point in the same direction: asbestos-contaminated cosmetic talc caused real harm, and the courts are holding manufacturers accountable. Government health agencies including the CDC and the EPA recognize that there is no safe level of asbestos exposure.

Frequently Asked Questions

References

1. [1] California Court of Appeal, Second Appellate District, Division Eight. LAOSD Asbestos Cases (Gary Chapman v. Avon Products, Inc.), No. B327749. Filed February 11, 2026; certified for publication March 4, 2026. Judicial Branch of California
2. [2] Emory TS, Maddox JC, Kradin RL. Malignant mesothelioma following repeated exposures to cosmetic talc: a case series of 75 patients. American Journal of Industrial Medicine. 2020. PMID: 32175619.
3. [3] Moline J, Bevilacqua K, Alexandri M, Gordon RE. Mesothelioma associated with the use of cosmetic talc. Journal of Occupational and Environmental Medicine. 2020. PMID: 31609780.
4. [4] Gordon RE, Fitzgerald S, Millette J. Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women. International Journal of Occupational and Environmental Health. 2014. PMID: 25185462.
5. [5] International Agency for Research on Cancer. IARC Monographs Volume 136: Talc and Acrylonitrile. WHO/IARC. 2024. IARC Publications
6. [6] National Cancer Institute. Mesothelioma — Patient Version. 2025. cancer.gov
7. [7] National Cancer Institute. Asbestos Exposure and Cancer Risk Fact Sheet. 2025. cancer.gov
8. [8] Occupational Safety and Health Administration. Asbestos — Overview and Standards. 2025. osha.gov
9. [9] U.S. Food and Drug Administration. Talc — Cosmetic Ingredient Safety Information. 2025. fda.gov
10. [10] Centers for Disease Control and Prevention. Malignant Mesothelioma — About. 2025. cdc.gov
11. [11] National Institute for Occupational Safety and Health. Asbestos — Workplace Safety and Health Topic. 2025. cdc.gov/niosh
12. [12] U.S. Environmental Protection Agency. Learn About Asbestos. 2025. epa.gov
13. [13] Legal Newsline. Appeals panel upholds $51M talc asbestos verdict vs Avon. 2026. Legal Newsline

Related Articles

• Vi-Jon Talc Trial: 6+ Manufacturers Face Mesothelioma Claims Beyond J&J — Why cosmetic-talc liability extends across the supply chain, not just to Johnson & Johnson
• J&J's Third Talc Bankruptcy Dismissed: The Red River Ruling — How federal courts rejected J&J's repeated attempts to resolve talc claims through bankruptcy
• Talc Mesothelioma Jury Verdicts Top $2.5 Billion — A tracker of the largest cosmetic-talc verdicts and what they signal for future claims
• Asbestos in Cosmetics: FDA Drops Testing Rule as 15% of Makeup Tests Positive — The regulatory gap that leaves cosmetic talc untested for asbestos
• 90,000 Talc Lawsuits: The Largest Mass Tort in American History — The full scope of cosmetic-talc litigation in the United States